Incidence Status and Factors Associated With Tyrosine Kinase Inhibitor-Induced Hypertension in Patients With Renal Cell Carcinoma.

Cancer Rep (Hoboken) · 2025 · PMC12046976 · PMID 40317701

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The breakdown of the drug efficacy classifications showed a trend similar to that of Cohort 1, and no prescriptions for ACE inhibitors were observed in Cohort 2 following the events. 3.2.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.